Literature DB >> 23855432

Primary Burkitt's lymphoma of endometrium and bilateral ovaries in a 6-year-old female: report of a rare entity and review of the published work.

Wasif Ali Z A Khan1, Kalpana A Deshpande, Madhumita Kurdukar, Purwa Patil, Harshal Mahure, Veena Pawar.   

Abstract

We report a case of a 6-year-old girl with primary Burkitt's lymphoma (BL) of endometrium and bilateral ovaries of 1-month duration. To the best of our knowledge, few cases of childhood primary BL of bilateral ovaries have been reported worldwide. However, extensive search of the published work did not reveal any case of primary BL of endometrium and both ovaries. Although rare, BL is a potentially curable malignancy with good prognosis.
© 2013 The Authors. Journal of Obstetrics and Gynaecology Research © 2013 Japan Society of Obstetrics and Gynecology.

Entities:  

Keywords:  Burkitts's lymphoma; endometrium; ovaries; primary

Mesh:

Year:  2013        PMID: 23855432     DOI: 10.1111/jog.12085

Source DB:  PubMed          Journal:  J Obstet Gynaecol Res        ISSN: 1341-8076            Impact factor:   1.730


  4 in total

1.  Primary ovarian Burkitt lymphoma: report of a case and review of literature.

Authors:  Hongliang Xu; Caixia Zhao; Qing Wang; Yong Chen; Weiqin Zhang; Yali Zhuang; Rongming Chen; Heping Zhang
Journal:  Int J Clin Exp Pathol       Date:  2022-03-15

Review 2.  Primary ovarian Burkitt's lymphoma: a rare oncological problem in gynaecology: a review of literature.

Authors:  Anna Stepniak; Piotr Czuczwar; Piotr Szkodziak; Ewa Wozniakowska; Slawomir Wozniak; Tomasz Paszkowski
Journal:  Arch Gynecol Obstet       Date:  2017-08-02       Impact factor: 2.344

3.  Primary bilateral ovarian Burkitt lymphoma; a rare issue in gynecologic oncology.

Authors:  Haneen Al-Maghrabi; Abdelrazak Meliti
Journal:  J Surg Case Rep       Date:  2018-05-18

4.  Epidemiological features for primary lymphoma of the female genital tract patients and development of a nomogram to predict survival.

Authors:  Fei Peng; Jingwen Li; Shidai Mu; You Qin; Jiewen Ma; Lisha Ai; Yu Hu
Journal:  Ann Med       Date:  2022-12       Impact factor: 4.709

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.